ajay sharma
Story Submitted
The mean progression-free Survival is >40 months with PRRT for Neuroendocrine Tumor Patients. pin.it
ajay sharma
4 months ago in Health
Several researches and clinical trials have shown that Peptide Receptor Radionuclide Therapy (PRRT) is an exciting and effective advancement in the treatment of Neuroendocrine Tumors (NETs). For more information on PRRT, do call us at +91 98111 27080, or write to us at [email protected] or visit https://nuclearmedicinetherapy.in/treatments/prrt
Neuroendocrine Tumor Patients can live Several Years longer with PRRT Treatment. pin.it
ajay sharma
4 months ago in Health
For more information on PRRT, do call us at +91 98111 27080, or write to us at [email protected] or visit https://nuclearmedicinetherapy.in/treatments/prrt
Increase survival, relieve symptoms, and improve quality of life with prrt. pin.it
ajay sharma
4 months ago in Health
The objective of Peptide Receptor Radionuclide Therapy (PRRT) is to provide symptom relief, slow down or stop tumor progression, to increase survival and improve quality of life.For more information on PRRT, do call us at +91 98111 27080, or write to us at [email protected] or visit https://nuclearmedicinetherapy.in/treatments/prrt
PRRT is Recommended by Nuclear Medicine Physicians For Net Patients only .. pin.it
ajay sharma
4 months ago in Health
For more information on PRRT, do call us at +91 98111 27080, or write to us at [email protected] or visit https://nuclearmedicinetherapy.in/treatments/prrt
Lu 177 Dotate Reduce the Risk of Cancer Spreading Growing, or Getting worse by 79% for patients with metastatic Net, as campared to a large dese of long acting octreetide. pin.it
ajay sharma
4 months ago in Health
Peptide receptor radionuclide therapy (PRRT) is fast proving to be a paradigm-shifting approach to the treatment of neuroendocrine tumors.For more information on PRRT, do call us at +91 98111 27080, or write to us at [email protected] or visit https://nuclearmedicinetherapy.in/treatments/prrt
Transarterial Radioembolization – TARE Treatment Procedure – Nuclear Medicine Therapy flic.kr
ajay sharma
5 months ago in Health
TARE is the short form of Transarterial Radioembolization. Transarterial Radioembolization is a technique by which we inject radioisotope directly into a liver tumor by cannulating the hepatic artery and then delivering the radioisotope directly into the tumor.
All you Need to Know about PRRT Therapy – Nuclear Medicine Therapy youtube.com
PRRT is a molecular technique in which a radioisotope which is labeled with a small body that actually targets a particular receptor which is known as the somatostatin receptors is used to treat a specific kind of tumor known as a Neuroendocrine Tumor.
How to treat large volume of Liver Metastases ? – Nuclear Medicine Therapy youtube.com
Neuroendocrine Tumors often present with large volume Liver Metastases and because these are relatively Indolent Tumors the patient often does not know that he has a Neuroendocrine Tumors specially those who have non-functioning Neuroendocrine Tumors.
The only center in India that provides Alpha PSMA Therapy For Metastatic Castration Resistant Prostate Cancer pin.it
ajay sharma
5 months ago in Health
The Department of NuclearMedicine at Fortis Memorial Research Institute FMRI, Gurugram, India, has treated more than 30 new patients of Castration Resistance Prostate Cancer CRPC with Ac225PSMATherapy. The results are extremely promising with 75-80% of patients showing evidence of significant radiological and biochemical response with a prolonged duration of response.For more information, call us at +91 98111 27080, or email us at [email protected]
PSMA Based therapies are effectively proven for patients with tumors resistant to chemotherapy drugs pin.it
ajay sharma
5 months ago in Health
Ac225 PSMA Therapy is a safe and tolerable treatment option for metastatic castration-resistant prostate cancer #mCRPC patients who have been previously treated with chemotherapy. Trials and research have shown that significant improvement in survival and quality of life can be achieved even in patients with residual disease which otherwise have very limited options.
Effectively proven for prostate cancer recurrence patient's Post Surgical treatment pin.it
ajay sharma
5 months ago in Health
PSMA-based therapies have been proven to be well-tolerated among prostate cancer recurrence patients whose disease has progressed after multiple standard therapies.
A proven treatment for metastatic prostate cancer pin.it
ajay sharma
5 months ago in Health
Clinical trials have shown that targeted radiation therapy Lu177PSMA617 has produced high response rate among men with prostate-specific membrane antigen-positive metastatic, castration-resistant prostate cancer.
A new beacon for hope for patients of prostate cancer pin.it
ajay sharma
5 months ago in Health
PSMA-based therapies have been proven effective for patients with Advanced Prostate Cancer for whom surgical and other medical options have already exhausted themselves. They offer a new ray of hope.
Advancements in PRRT for treating Neuroendocrine tumours and other cancers. A look at Targeted Alpha pin.it
ajay sharma
5 months ago in Health
PRRT is a curative option for non-localised, heterogeneous, metastatic neuroendocrine tumours. PRRT has proven to be the most promising treatment modality amongst various systemic treatments such as Somatostatin Analogues, Chemotherapy, Molecular Targeted Treatments, Alpha Interferon etc.
Advancements in PRRT for treating Neuroendocrine tumours and other cancers. A look at Targeted Alpha nmt-ajaysharma.livejournal.com
ajay sharma
5 months ago in Health
PRRT is a curative option for non-localised, heterogeneous, metastatic neuroendocrine tumours. PRRT has proven to be the most promising treatment modality amongst various systemic treatments such as Somatostatin Analogues, Chemotherapy, Molecular Targeted Treatments, Alpha Interferon etc.
Lu177 PRRT For Neuroendocrine Tumors (Nets) nuclearmedicinetreatment.blogspot.com
ajay sharma
5 months ago in Health
Unlike healthy cells, the neuroendocrine tumor cells or NET cells have proteins on their cell surface. These proteins, also known as receptors, bind themselves to hormones, such as somatostatin. Peptide Receptor Radionuclide Therapy or PRRT with lutetium 177 dotatate or Lu177 targets these receptors with radiopeptides and deliver a high dose of radiation to the tumor cells.
Advancements in PRRT for treating Neuroendocrine tumours and other cancers. A look at Targeted Alpha nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
PRRT is a curative option for non-localised, heterogeneous, metastatic neuroendocrine tumours. PRRT has proven to be the most promising treatment modality amongst various systemic treatments such as Somatostatin Analogues, Chemotherapy, Molecular Targeted Treatments, Alpha Interferon etc.
Lu177 PRRT For Neuroendocrine Tumors (Nets) nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
Lu177 Treatment in India, Lutetium Therapy in India, Lutetium Treatment in India, Neuroendocrine Cancer Treatment in India, Nuclear Medicine Therapy in India, Peptide Receptor Radionuclide Therapy in India, PRRT in India, PRRT in Neuroendocrine Tumors, PRRT Therapy Side Effects, PRRT Treatment for Neuroendocrine
Lu177 PRRT For Neuroendocrine Tumors Nets vimeo.com
ajay sharma
5 months ago in Health
PRRT or Peptide Receptor Radionuclide Therapy is a type of Nuclear Medicine Therapy in which a cell-targeting protein or peptide is combined with a small amount of radioactive material that created a special type of radiopharmaceutical known as a Radiopeptide. This radiopeptide is injected into a Neuroendocrine Tumor patient’s bloodstream.Details Available at https://nuclearmedicinetherapy.in/blog/lu177-prrt-for-neuroendocrine-tumors-nets
Long Term effects of Y90 | Dr. Ishita B Sen – Nuclear Medicine Therapy vimeo.com
ajay sharma
5 months ago in Health
In this video Dr. Ishita B. Sen, Head Of Department of Nuclear Medicine at Fortis Memorial Research Institute explains about the long-term effects of Y-90 and how it is performed. know more info at https://nuclearmedicinetherapy.in/
Cancer Care During Covid-19 | Dr. Ishita B. Sen MBBS, DRM,DNB (Nuclear Medicine) – Nuclear Medicine Therapy flic.kr
ajay sharma
5 months ago in Health
In this video Dr. Ishita B. Sen, Head Of Department of Nuclear Medicine at Fortis Memorial Research Institute explains why patients should not hold off on their treatments during to Covid-19. know more info at nuclearmedicinetherapy.in …
Is PRRT Treatment Safe for You? | Nuclear Medicine Therapy nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
For those who want to go through this treatment the basic question arises are How PRRT Performed? Is it Safe? What are the advantages and what are the post therapy guidelines?
Which Patients can benefit with PRRT? nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
PRRT is a procedure that is used for treating Neuroendocrine Tumours (NETs) – gastro-entero-pancreatic NETs, which arise from the stomach, gastrointestinal tract, pancreas, islet cell carcinomas of the pancreas (These NETs are included in the US Federal Drug Administration {FDA} approved indication)
131 Iodine MIBG Therapy for Pediatric Neuroblastoma | Nuclear Medicine Therapy nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
The Nuclear Medicine Therapy Centre at Fortis Memorial Research Institute (FMRI) is the Only Centre in India Offering Myeloblative MIBG Therapy for High Risk Neuroblastomas in Children. …
An In-Depth look at Prostate Cancer nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
What is prostate cancer? What are the symptoms of prostate cancer and what are the screening and diagnosis process? you will get an in-depth information on this. …
Castrate-Resistant-Prostate-Cancer-Treatment-–-Ac225-PSMA-Therapy-Targeted-Alpha-Therapy nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
For CRPC patients receiving Ac225 PSMA Therapy, there cycles of treatments at intervals of two months are administered. And depending upon the response to therapy, further salvage cycles may be given.
Lowest Cost of Lu177 PSMA Therapy in India nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
The cost of Lu177 PSMA Treatment at Fortis Memorial Research Institute (FMRI) is half the cost of treatment in Thailand & Malaysia and one-third the cost of treatment in Germany.
Medical Travel to India’s Fortis Memorial Research Institute – My Experience nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
In this blog, the Patient explains his experience of Medical Travel to India's Fortis Memorial Research Institute, Gurugram for the Treatment of Prostate Cancer.
225ac-psma-617 – A New Beginning in the Treatment of Chemotherapy-Naïve Prostate Cancer Patients nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
The 225ac labeled derivative – 225Ac-PSMA-617, has shown remarkable therapeutic efficacy, especially in metastatic castrate-resistant prostate cancer (mcrpc) patients. More details available at www.nuclearmedicinetherapy.in/blog.
Everything you need to know about Alpha PSMA Therapy nuclearmedicinetherapy.in
ajay sharma
5 months ago in Health
Targeted Alpha Therapy or Alpha PSMA Therapy is a targeted, selective internal medicine cellular level radiotherapy used to control advanced prostate and prostate cancer.
